Trademark applications and grants for Bukwang Pharm Co L T D. Bukwang Pharm Co L T D has 3 trademark applications. The latest application filed is for "REBOVIR"
Patent Application | Date |
---|---|
COMPOSITION FOR TREATING CHRONIC HEPATITIS B, CONTAINING CLEVUDINE AND ADEFOVIR DIPIVOXIL 20130059812 - 13/697667 Lee; Sung-Koo ;   et al. | 2013-03-07 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "REBOVIR" 79023124 |
REBOVIR 2005-11-01 |
![]() "REVOVIR" 79023125 |
REVOVIR 2005-11-01 |
![]() "LEVOVIR" 79012146 |
LEVOVIR 2004-10-12 |
NCAGE Code | 2747F | BUKWANG PHARM CO., LTD. |
CAGE Code | 2747F | BUKWANG PHARM CO., LTD. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.